Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.2850 (1.47%) ($8.2850 - $8.2850) on Mon. May. 1, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.76% (three month average) | RSI | 70 | Latest Price | $8.2850(1.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 0.9% a day on average for past five trading days. | Weekly Trend | EDIT advances 4.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(63%) IBB(50%) IWC(50%) IWO(46%) IWM(45%) | Factors Impacting EDIT price | EDIT will decline at least -2.38% in a week (0% probabilities). SMH(-16%) IGOV(-15%) VXX(-9%) VIXM(-9%) BNDX(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.38% (StdDev 4.76%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.01(3.43%) | 10 Day Moving Average | $7.99(3.69%) | 20 Day Moving Average | $7.57(9.45%) | To recent high | -27.5% | To recent low | 30.4% | Market Cap | $515m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |